169 related articles for article (PubMed ID: 17045671)
1. Brain natriuretic peptide as marker of myocardial iron load in beta-thalassemia.
Nikolidakis S; Flessa C; Nikolaou N; Gotsis ED; Koutouzis M; Polyhronaki E; Vrettou E; Kyriakides ZS
Int J Cardiol; 2007 Jun; 118(3):408-9. PubMed ID: 17045671
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients.
Taher AT; Musallam KM; Wood JC; Cappellini MD
Am J Hematol; 2010 Apr; 85(4):288-90. PubMed ID: 20143405
[No Abstract] [Full Text] [Related]
4. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia.
Origa R; Barella S; Argiolas GM; Bina P; Agus A; Galanello R
Haematologica; 2008 Jul; 93(7):1095-6. PubMed ID: 18508795
[No Abstract] [Full Text] [Related]
5. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
6. Clinics in diagnostic imaging (29). Thalassaemia major with iron overload.
Griffith JF; King AD; Chan YL
Singapore Med J; 1997 Sep; 38(9):402-4. PubMed ID: 9407769
[TBL] [Abstract][Full Text] [Related]
7. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events.
Patton N; Brown G; Leung M; Bavishi K; Taylor J; Lloyd J; Lee SH; Tay L; Worthley S
Intern Med J; 2010 Jun; 40(6):419-26. PubMed ID: 19460052
[TBL] [Abstract][Full Text] [Related]
8. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U
Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.
Xu LH; Fang JP; Xu HG; Weng WJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):702-7. PubMed ID: 21970505
[TBL] [Abstract][Full Text] [Related]
10. Significance of circulating B-type natriuretic peptide in sepsis.
Fujita T
Arch Surg; 2008 Oct; 143(10):1021-2; author reply 1022-3. PubMed ID: 18936386
[No Abstract] [Full Text] [Related]
11. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
12. The role of adrenomedullin and brain natriuretic peptide levels in acute rheumatic fever in adults.
Bayram E; Kocatürk H; Yücel O; Atalay C; Colak MC; Ateşal S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):188-91. PubMed ID: 18524724
[TBL] [Abstract][Full Text] [Related]
13. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major.
Ehsan L; Rashid M; Alvi N; Awais K; Nadeem O; Asghar A; Sajjad F; Fatima M; Qidwai A; Hussain S; Hasan E; Brown N; Altaf S; Hasan B; Kirmani S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27285. PubMed ID: 29893484
[TBL] [Abstract][Full Text] [Related]
15. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of myocardial iron overload using cardiovascular magnetic resonance imaging.
Mavrogeni S; Pepe A; Lombardi M
Hellenic J Cardiol; 2011; 52(5):385-90. PubMed ID: 21940285
[No Abstract] [Full Text] [Related]
17. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.
Sir JJ; Chung WY; Hwang SJ; Kang HJ; Cho YS; Koo BK; Chae IH; Choi DJ; Kim HS; Sohn DW; Kim CH; Oh BH; Park YB; Choi YS
Int J Cardiol; 2008 Jun; 126(3):322-32. PubMed ID: 17544525
[TBL] [Abstract][Full Text] [Related]
19. Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis.
Koohi F; Kazemi T; Miri-Moghaddam E
Ann Hematol; 2019 Jun; 98(6):1323-1331. PubMed ID: 30729283
[TBL] [Abstract][Full Text] [Related]
20. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
